115 related articles for article (PubMed ID: 2855613)
1. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
Moosdeen F; Williams J; Yamabe S
Chemioterapia; 1987 Jun; 6(2 Suppl):206-7. PubMed ID: 2855613
[No Abstract] [Full Text] [Related]
2. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Grace ME; Fu KP; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
[TBL] [Abstract][Full Text] [Related]
3. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
Nord CE
J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
[No Abstract] [Full Text] [Related]
4. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
Prabhakaran K; Harris EB; Randhawa B; Hastings RC
Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
[TBL] [Abstract][Full Text] [Related]
5. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
Moosdeen F; Keeble J; Williams JD
Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
7. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
8. Detection of bacterial strains producing sulbactam- or tazobactam-sensitive beta-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibiotics.
Banic S
APMIS; 2006 Jan; 114(1):3-9. PubMed ID: 16499654
[TBL] [Abstract][Full Text] [Related]
9. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
Campos M; Alarcón MA; González H; Sánchez R
Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
[TBL] [Abstract][Full Text] [Related]
10. Evolution of beta-lactamase inhibitors.
Jackson D
Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
[TBL] [Abstract][Full Text] [Related]
11. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
Grimm H
Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
[TBL] [Abstract][Full Text] [Related]
12. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.
Kitzis MD; Billot-Klein D; Goldstein FW; Williamson R; Tran Van Nhieu G; Carlet J; Acar JF; Gutmann L
Antimicrob Agents Chemother; 1988 Jan; 32(1):9-14. PubMed ID: 2831817
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Kitzis MD; Ferré B; Coutrot A; Acar JF; Gutmann L
Eur J Clin Microbiol Infect Dis; 1989 Sep; 8(9):783-8. PubMed ID: 2556277
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).
Eliopoulos GM; Klimm K; Ferraro MJ; Jacoby GA; Moellering RC
Diagn Microbiol Infect Dis; 1989; 12(6):481-8. PubMed ID: 2560420
[TBL] [Abstract][Full Text] [Related]
15. The effects of three beta-lactamase inhibitors: YTR830H, sulbactam and clavulanic acid on the growth of human cells in culture.
Yamabe S; Adachi K; Watanabe M; Ueda S
Chemioterapia; 1987 Oct; 6(5):337-40. PubMed ID: 2827899
[TBL] [Abstract][Full Text] [Related]
16. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
Cullmann W; Binder S; Stieglitz M
Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
[TBL] [Abstract][Full Text] [Related]
17. Overcoming enzymatic resistance in bacteria: impact on future therapy.
Labia R; Barthélémy M; Péduzzi J; Morand A; Tiwari K; Kazmierczak A
J Int Med Res; 1990; 18 Suppl 4():48D-57D. PubMed ID: 2282969
[TBL] [Abstract][Full Text] [Related]
18. [Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus].
Kitzis MD; Goldstein FW; Labia R; Acar JF
Ann Microbiol (Paris); 1983; 134A(2):163-8. PubMed ID: 6307103
[TBL] [Abstract][Full Text] [Related]
19. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Baumgärtner M; Müller HP; Wundt W
Arzneimittelforschung; 1983; 33(12):1615-9. PubMed ID: 6320836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]